CYP19 gene polymorphism in endometrial cancer patients

Citation
Lm. Berstein et al., CYP19 gene polymorphism in endometrial cancer patients, J CANC RES, 127(2), 2001, pp. 135-138
Citations number
16
Categorie Soggetti
Onconogenesis & Cancer Research
Journal title
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
ISSN journal
01715216 → ACNP
Volume
127
Issue
2
Year of publication
2001
Pages
135 - 138
Database
ISI
SICI code
0171-5216(200102)127:2<135:CGPIEC>2.0.ZU;2-7
Abstract
Purpose: Initiation/promotion of endometrial cancer is known to be associat ed with estrogenic influence. Therefore, it is possible that some allelic p olymorphisms of the genes involved in steroidogenesis or steroid metabolism contribute to endometrial cancer susceptibility. Methods: Here, we compare d CYP19 (aromatase) gene polymorphism in 85 endometrial cancer patients and in 110 non-affected women. Results: The genotypes containing the longest a lleles (A6 and A7) of CYP19 were found to be over-represented in patients a s compared to controls. In addition, these genotypes demonstrated a tendenc y to be associated with increased concentrations of estradiol and testoster one in postmenopausal patients. Conclusions: Thus, CYP19 poly, morphism mig ht be one of the genetic risk factors for endometrial cancer development.